Hong Kong Prohibits CBD Products: 7-Year Imprisonment and Heavy Fines

Jan.12.2023

Hong Kong bans all CBD products, adding them to its Dangerous Drugs Ordinance, with the possibility of severe punishments.

Hong Kong, China recently announced that all products containing cannabidiol (CBD) will be banned starting February 1st. CBD will be added to the Dangerous Drugs Ordinance (DDO), which already includes over 200 substances such as fentanyl, ketamine, heroin, and various psychoactive compounds like MDMA.

CBD will now be included in the existing list of "cannabinol and its tetrahydro derivative (THC); as well as 3-alkyl homologues." As a result of this change, anyone who possesses or consumes CBD will face a maximum of seven years in prison and a fine of up to HKD 1 million (approximately RMB 870,000).

According to Lexology, manufacturers of CBD may also face life imprisonment.

Although many users around the world have been touting the anti-anxiety and pain-relieving properties of CBD, the Hong Kong Security Bureau believes that these claims "lack authoritative scientific evidence." This directive appears to be consistent with China's ban on the use of CBD in cosmetics implemented last year.

Currently, it is unclear whether other cannabinoids such as CBG, CBDV, CBC, etc. will be included in the ban. However, based on a memorandum from the Narcotics Division in November 2022, the Hong Kong government appears to be primarily concerned about the possibility of CBD products containing trace amounts of THC, either through breakdown or conversion, and the lack of international regulations specifically for these products.

Article Related Reading: Hong Kong plans to completely ban the sale of CBD products by the end of 2022.

#CBD #Products #Hong Kong #Hong Kong, China #Product

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Kyrgyzstan considers six-month ban on e-cigarette and e-cigarettee-liquid imports

According to Kyrgyz media, the Ministry of Economy and Commerce has launched a public discussion on a draft decree proposing a six-month ban on the import of e-cigarettes and nicotine-containing liquids. The measure, based on Article 15-1 of the Law “On Protecting Citizens’ Health from the Consequences of Tobacco and Nicotine Use,” aims to safeguard public health and prevent youth nicotine addiction.

Nov.12 by 2FIRSTS.ai

Ukraine Military Voices Concern Over Potential Vape and Pouch Ban

Verkhovna Rada is reviewing six bills to regulate new nicotine products such as pouches and vapes. The main bill, No.14110, proposes a total ban on production, import, and sale, while alternative proposals seek regulation instead of prohibition.

Nov.10 by 2FIRSTS.ai

Illegal tobacco syndicate dominates Australia’s vape market through threats and extortion

Australia’s The Age has revealed that a local tobacco cartel is working with a crime syndicate to dominate the illicit vape trade. The Australian Border Force (ABF) intercepted 115,200 vapes worth A$4.5 million disguised as “furniture” at Sydney port. Authorities say over 12 million illegal vapes have been seized since 2024.

Nov.03

RLX Technology Inc. (NYSE: RLX) Q3 2025 Financial Results: Net Revenue US$158.6 Million; International Business Accounts for 72%

RLX Technology Inc. (NYSE: RLX) announced its unaudited financial results for the third quarter of 2025. The company reported net revenue of RMB 1.13 billion, up 49.3% year-on-year, and adjusted net profit of RMB 295.4 million, up 1.4% quarter-on-quarter. International business contributed 72% of total revenue, reflecting robust financial performance and continued shareholder returns.

Nov.14